Novadaq Technologies Company Profile (NASDAQ:NVDQ)

About Novadaq Technologies (NASDAQ:NVDQ)

Novadaq Technologies logoNOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Imaging Systems
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NVDQ
  • CUSIP: N/A
  • Web:
  • Market Cap: $679.41 million
  • Outstanding Shares: 57,822,000
Average Prices:
  • 50 Day Moving Avg: $11.68
  • 200 Day Moving Avg: $9.03
  • 52 Week Range: $5.84 - $12.74
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.32
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $83.87 million
  • Price / Sales: 8.10
  • Book Value: $1.54 per share
  • Price / Book: 7.63
  • EBITDA: ($50,470,000.00)
  • Net Margins: -66.61%
  • Return on Equity: -51.89%
  • Return on Assets: -40.92%
  • Debt-to-Equity Ratio: 0.11%
  • Current Ratio: 3.49%
  • Quick Ratio: 3.30%
  • Average Volume: 1.41 million shs.
  • Beta: 0.71
  • Short Ratio: 0.72

Frequently Asked Questions for Novadaq Technologies (NASDAQ:NVDQ)

What is Novadaq Technologies' stock symbol?

Novadaq Technologies trades on the NASDAQ under the ticker symbol "NVDQ."

How were Novadaq Technologies' earnings last quarter?

Novadaq Technologies Inc. (NASDAQ:NVDQ) released its earnings results on Wednesday, May, 3rd. The company reported ($0.24) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.21) by $0.03. The business earned $21.08 million during the quarter, compared to analyst estimates of $20.12 million. Novadaq Technologies had a negative net margin of 66.61% and a negative return on equity of 51.89%. View Novadaq Technologies' Earnings History.

When will Novadaq Technologies make its next earnings announcement?

Novadaq Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Novadaq Technologies.

Where is Novadaq Technologies' stock going? Where will Novadaq Technologies' stock price be in 2017?

13 equities research analysts have issued twelve-month target prices for Novadaq Technologies' stock. Their forecasts range from $11.00 to $13.25. On average, they expect Novadaq Technologies' share price to reach $11.86 in the next twelve months. View Analyst Ratings for Novadaq Technologies.

What are analysts saying about Novadaq Technologies stock?

Here are some recent quotes from research analysts about Novadaq Technologies stock:

  • 1. According to Zacks Investment Research, "Novadaq Technologies Inc. develops, manufactures and markets real-time fluorescence imaging products for use in the operating room and other clinical settings. The company's key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. It provides SPY imaging systems which enables surgeons to the visualize blood flow in vessels, co-joined vessels and micro-vessels. Novadaq Technologies Inc. is headquartered in Mississauga, Canada. " (8/18/2017)
  • 2. Northland Securities analysts commented, "We feel somewhat vindicated that the core biz was not doing OK, forward estimates were out of whack, and the bullish sell-side commentary at large was not based on a true understanding of the science…or ground fundamentals…Yes, it is water under the bridge now…..but sometimes postmortems are necessary." (8/14/2017)
  • 3. Stifel Nicolaus analysts commented, "We continue to believe the underlying value proposition of the larger NVDQ story remains unchanged. The combination of our high level of conviction in the company's highly differentiated and clinically relevant technology, a very solid balance sheet (at least 3-4 years of cash with revolver) with no need for near-term dilutive financing, and the shares' discounted valuation are enough, in our view, to continue recommending the shares... . In the long run, if these initiatives are even remotely successful, we believe it argues for a much higher value for the company, standalone or for potential strategic acquirers. On the basis of our new, now lower 2017 projections, adjusted down largely to reflect the impact of a new flexible capital acquisition model, we lower our TP to $10 (from $16)." (3/1/2017)

Who are some of Novadaq Technologies' key competitors?

Who are Novadaq Technologies' key executives?

Novadaq Technologies' management team includes the folowing people:

  • William A. MacKinnon, Chairman of the Board
  • Rick Mangat Ph.D., President, Chief Executive Officer
  • Roger Deck, Chief Financial Officer
  • Lori Swalm, Vice President of Marketing
  • Derrick Guo, General Counsel, Corporate Secretary
  • Anthony F. Griffiths, Lead Independent Director
  • Lisa N. Colleran, Director
  • Karen A. Licitra, Director
  • Patrice E. Merrin, Independent Director
  • Thomas G. Wellner, Independent Director

How do I buy Novadaq Technologies stock?

Shares of Novadaq Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Novadaq Technologies' stock price today?

One share of Novadaq Technologies stock can currently be purchased for approximately $11.75.

MarketBeat Community Rating for Novadaq Technologies (NASDAQ NVDQ)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  261 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  407
MarketBeat's community ratings are surveys of what our community members think about Novadaq Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Novadaq Technologies (NASDAQ:NVDQ) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 11 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.15)
Consensus Price Target: $11.86 (0.91% upside)
Consensus Price Target History for Novadaq Technologies (NASDAQ:NVDQ)
Price Target History for Novadaq Technologies (NASDAQ:NVDQ)
Analysts' Ratings History for Novadaq Technologies (NASDAQ:NVDQ)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/1/2017Royal Bank Of CanadaReiterated RatingHold$11.75N/AView Rating Details
9/1/2017Canaccord GenuityReiterated RatingHold$11.75LowView Rating Details
8/14/2017Northland SecuritiesReiterated RatingHold$11.75MediumView Rating Details
7/13/2017JMP SecuritiesReiterated RatingOutperform -> Market PerformLowView Rating Details
6/20/2017First AnalysisDowngradeOverweight -> Equal WeightLowView Rating Details
6/20/2017ScotiabankLower Price TargetOutperform$15.50 -> $13.25LowView Rating Details
6/20/2017Stifel NicolausDowngradeBuy -> Hold$11.75LowView Rating Details
6/19/2017Craig HallumDowngradeBuy -> Hold$11.75LowView Rating Details
6/19/2017WedbushDowngradeOutperform -> NeutralN/AView Rating Details
3/1/2017Feltl & Co.DowngradeBuy -> HoldN/AView Rating Details
1/11/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
11/16/2016BTIG ResearchReiterated RatingHoldN/AView Rating Details
11/3/2016Noble FinancialDowngradeStrong-Buy -> BuyN/AView Rating Details
3/11/2016Piper Jaffray CompaniesReiterated RatingBuyN/AView Rating Details
(Data available from 10/17/2015 forward)


Earnings History for Novadaq Technologies (NASDAQ:NVDQ)
Earnings by Quarter for Novadaq Technologies (NASDAQ:NVDQ)
Earnings History by Quarter for Novadaq Technologies (NASDAQ NVDQ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1($0.21)($0.24)$20.12 million$21.08 millionViewListenView Earnings Details
2/28/201712/31/2016($0.17)($0.32)$21.08 million$20.10 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.16)($0.19)$22.21 million$22.16 millionViewN/AView Earnings Details
7/27/2016Q216($0.14)($0.29)$19.97 million$20.12 millionViewListenView Earnings Details
4/27/2016Q116($0.17)($0.14)$17.49 million$17.70 millionViewListenView Earnings Details
2/17/2016Q415($0.15)($0.17)$19.02 million$20.00 millionViewListenView Earnings Details
10/28/2015Q315($0.20)($0.11)$16.32 million$17.04 millionViewListenView Earnings Details
7/28/2015Q215($0.17)($0.22)$13.99 million$15.07 millionViewListenView Earnings Details
4/28/2015Q115($0.09)($0.20)$13.10 million$11.70 millionViewN/AView Earnings Details
2/25/2015Q4 2014($0.09)($0.10)$13.00 million$13.02 millionViewN/AView Earnings Details
11/6/2014Q414($0.07)($0.17)$12.10 million$12.10 millionViewN/AView Earnings Details
8/5/2014Q2($0.07)($0.08)$11.33 million$11.20 millionViewN/AView Earnings Details
5/7/2014Q114($0.05)($0.08)$10.33 million$10.30 millionViewN/AView Earnings Details
2/6/2014Q4($0.03)($0.06)$10.37 million$10.70 millionViewN/AView Earnings Details
10/22/2013Q313($0.03)($0.14)$8.68 million$8.90 millionViewN/AView Earnings Details
8/1/2013Q213($0.02)($0.05)$7.89 million$8.10 millionViewN/AView Earnings Details
4/29/2013Q113($0.04)($0.02)$6.94 million$7.30 millionViewN/AView Earnings Details
2/7/2013Q412($0.05)($0.01)$6.43 million$6.80 millionViewN/AView Earnings Details
11/2/2012Q312($0.05)($0.03)$5.75 million$5.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Novadaq Technologies (NASDAQ:NVDQ)
2017 EPS Consensus Estimate: ($0.72)
2018 EPS Consensus Estimate: ($0.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175($0.23)($0.15)($0.19)
Q2 20175($0.25)($0.14)($0.20)
Q3 20175($0.22)($0.11)($0.18)
Q4 20174($0.23)($0.08)($0.15)
Q1 20182($0.25)($0.16)($0.21)
Q2 20181($0.24)($0.24)($0.24)
Q3 20181($0.23)($0.23)($0.23)
Q4 20181($0.22)($0.22)($0.22)
(Data provided by Zacks Investment Research)


Dividend History for Novadaq Technologies (NASDAQ:NVDQ)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Novadaq Technologies (NASDAQ:NVDQ)
No insider trades for this company have been tracked by


Headline Trends for Novadaq Technologies (NASDAQ:NVDQ)
Latest Headlines for Novadaq Technologies (NASDAQ:NVDQ)
DateHeadline logoNovadaq Technologies Inc. (NVDQ) Receives Consensus Recommendation of "Hold" from Analysts - October 11 at 2:32 AM logoNovadaq Technologies Inc (NVDQ) Given Average Rating of "Hold" by Analysts - September 16 at 2:46 AM logoNovadaq Technologies, Inc. – Value Analysis (NASDAQ:NVDQ) : September 2, 2017 - September 2 at 6:56 AM logoNovadaq Technologies' (NVDQ) "Hold" Rating Reaffirmed at Royal Bank Of Canada - September 2 at 6:56 AM logoNovadaq Technologies Inc (NVDQ) Stock Rating Reaffirmed by Canaccord Genuity - September 1 at 4:46 PM logoHead to Head Survey: Novadaq Technologies (NVDQ) & NxStage Medical (NXTM) - August 30 at 10:24 PM logoNovadaq Technologies, Inc. breached its 50 day moving average in a Bullish Manner : NVDQ-US : August 29, 2017 - August 30 at 7:24 AM logoHead to Head Survey: NxStage Medical (NXTM) vs. Novadaq Technologies (NVDQ) - August 29 at 4:22 PM logoComparing EndoChoice Holdings (GI) and Novadaq Technologies (NVDQ) - August 29 at 12:22 AM logoEndoChoice Holdings (GI) versus Novadaq Technologies (NVDQ) Head to Head Analysis - August 28 at 4:20 PM logo$26.19 Million in Sales Expected for Novadaq Technologies Inc (NVDQ) This Quarter - August 28 at 6:38 AM logo-$0.21 EPS Expected for Novadaq Technologies Inc (NVDQ) This Quarter - August 26 at 10:22 AM logoNovadaq Technologies Inc (NVDQ) Given Average Recommendation of "Hold" by Brokerages - August 22 at 2:32 AM logoNovadaq Technologies (NVDQ) versus Analogic Corporation (ALOG) Financial Analysis - August 22 at 2:10 AM logoReviewing Novadaq Technologies (NVDQ) & EndoChoice Holdings (GI) - August 15 at 4:10 AM logoNovadaq Technologies Inc (NASDAQ:NVDQ) Given Hold Rating at Northland Securities - August 14 at 11:41 AM logoShort Interest in Novadaq Technologies Inc (NASDAQ:NVDQ) Declines By 44.0% - August 13 at 2:20 AM logoHead-To-Head Analysis: Novadaq Technologies (NASDAQ:NVDQ) and NxStage Medical (NXTM) - August 11 at 5:11 PM logoNOVADAQ Receives Court Approval for Arrangement With Stryker - GlobeNewswire (press release) - August 10 at 6:22 AM logoNovadaq Technologies Inc (NASDAQ:NVDQ) Expected to Post Quarterly Sales of $23.56 Million - August 9 at 7:10 AM logoComparing Novadaq Technologies (NVDQ) & Analogic Corporation (ALOG) - August 6 at 2:22 PM logoNovadaq Announces Voting Results of Special Meeting of Shareholders - GlobeNewswire (press release) - August 4 at 3:51 PM logoHead to Head Analysis: Novadaq Technologies (NVDQ) and Analogic Corporation (ALOG) - July 30 at 7:27 AM logoNovadaq Technologies Inc (NASDAQ:NVDQ) Short Interest Down 24.6% in July - July 30 at 7:03 AM logoNovadaq Technologies Inc (NVDQ) Given Average Recommendation of "Hold" by Analysts - July 28 at 10:02 AM logoLeading Advisory Firms ISS and Glass Lewis Support Plan of Arrangement Between NOVADAQ Technologies Inc. and ... - GlobeNewswire (press release) - July 24 at 8:58 AM logoLeading Advisory Firms ISS and Glass Lewis Support Plan of Arrangement Between NOVADAQ Technologies Inc. and Stryker Corporation - July 24 at 8:58 AM logo Analysts Expect Novadaq Technologies Inc (NVDQ) to Announce -$0.23 EPS - July 18 at 8:24 PM logoNovadaq Technologies Inc (NVDQ) Rating Reiterated by JMP Securities - July 16 at 5:50 PM logoShort Interest in Novadaq Technologies Inc (NASDAQ:NVDQ) Declines By 64.4% - July 15 at 7:16 AM logoNovadaq Technologies Inc (NVDQ) Stock Rating Lowered by Canaccord Genuity - July 10 at 7:50 AM logoAnalyzing Avinger (AVGR) and Novadaq Technologies (NVDQ) - July 5 at 2:12 PM logoNovadaq Technologies Inc (NVDQ) Receives Consensus Rating of "Hold" from Analysts - July 3 at 10:16 AM logoComparing Novadaq Technologies (NASDAQ:NVDQ) and Avinger (AVGR) - July 1 at 10:04 PM logoWhy Novadaq Technologies Inc. Is Skyrocketing Today - June 20 at 9:55 AM logoWall Street's M&A Chatter From June 19: CareerBuilder, EQT-Rice Energy, Novadaq-Stryker - Benzinga - June 20 at 7:38 AM logoNOVADAQ Enters Into Agreement to be Acquired by Stryker Corporation - GlobeNewswire (press release) - June 20 at 7:38 AM logoBUZZ-US STOCKS ON THE MOVE-PerkinElmer, EQT Corp, Rice Energy, Novadaq, Celsion, Clovis - Nasdaq - June 19 at 6:01 PM logoBay Street Set For Subdued Session -- Canadian Commentary - June 19 at 11:00 AM logoNOVADAQ Technologies Inc. (NVDQ) Has Jumped To An 8-Month High After Merger - June 19 at 11:00 AM logoNovadaq Technologies (NVDQ) Misses Q1 EPS by 3c; Guides Revs In-Line - - May 4 at 1:07 AM logoNOVADAQ Announces Fourth Quarter and Full Year 2016 Financial Results - February 28 at 6:59 PM logoNOVADAQ to Report Fourth Quarter and Full Year 2016 Financial ... - GlobeNewswire (press release) - February 16 at 6:29 PM logoInconsistency And Credibility Bedevil Novadaq Technologies - Seeking Alpha - February 16 at 6:29 PM logoInconsistency And Credibility Bedevil Novadaq Technologies - Seeking Alpha - February 16 at 6:29 PM logoHere's Why Novadaq Technologies Inc. Is Tanking Today - January 11 at 12:32 PM logoNovadaq Technologies (NVDQ) Guides Q4, FY17 and FY17 Below the Street - - January 11 at 5:49 AM logoStudy: DermACELL® demonstrates superior clinical outcomes compared to AlloDerm® in breast reconstruction - January 10 at 7:48 PM logoNovadaq Technologies (NVDQ) Guides Q4, FY17 and FY17 Below the Street - January 10 at 7:48 PM logo12:21 pm Novadaq Tech.: LifeNet Health's Dermacell acellular dermal matrix demonstrated statistically significant improvements compared to AlloDerm Ready-To-Use according to the results of a study published by the journal Plastic & Reconstr - January 10 at 7:48 PM



Novadaq Technologies (NVDQ) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.